HER2-targeted antibody-drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia.
Rainone M, Behrendt CE, Kasparian S, Nguyen T, Sedrak MS, Lavasani S, Stewart DB, Yuan Y, Mortimer JE, Waisman JR, Patel N, Pullarkat V.
Rainone M, et al. Among authors: kasparian s.
Breast Cancer. 2023 Sep;30(5):796-801. doi: 10.1007/s12282-023-01473-2. Epub 2023 Jun 16.
Breast Cancer. 2023.
PMID: 37326930
Free PMC article.